C21H22N2O8
Neat
430.41
Room Temperature
4-Epidemethyltetracycline; 129044-45-7; B6EUU1IGGY; (4R, 4aS, 5aS, 6S, 12aR)-4-(dimethylamino)-1, 6, 10, 11, 12a-pentahydroxy-3, 12-dioxo-4a, 5, 5a, 6-tetrahydro-4H-tetracene-2-carboxamide; (4R, 4aS, 5aS, 6S, 12aS)-4-(Dimethylamino)-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-, (4R, 4aS, 5aS, 6S, 12aS)-; UNII-B6EUU1IGGY; Demeclocycline EP Impurity C; Chlortetracycline hydrochloride impurity C [EP]; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-, (4R-(4alpha, 4abeta, 5abeta, 6alpha, 12abeta))-; CS-0164642; Q27274433; CHLORTETRACYCLINE HYDROCHLORIDE IMPURITY C [EP IMPURITY]; Demeclocycline EP Impurity C; Chlortetracycline EP Impurity C; (4R, 4aS, 5aS, 6S, 12aS)-4-(dimethylamino)-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydrotetracene-2-carboxamide? (Minocycline Impurity pound(c); 2-Naphthacenecarboxamide, 4-(dimethylamino)-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-, (4R, 4aS, 5aS, 6S, 12aS)-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1, 4, 4a, 5, 5a, 6, 11, 12a-octahydro-3, 6, 10, 12, 12a-pentahydroxy-1, 11-dioxo-, [4; 2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1, 4, 4A, 5, 5A, 6, 11, 12A-OCTAHYDRO-3, 6, 10, 12, 12A-PENTAHYDROXY-1, 11-DIOXO-, (4R-(4.ALPHA., 4A.BETA., 5A.BETA., 6.ALPHA. and 12A.BETA.))-
(4R, 4aS, 5aS, 6S, 12aR)-4-(dimethylamino)-1, 6, 10, 11, 12a-pentahydroxy-3, 12-dioxo-4a, 5, 5a and 6-tetrahydro-4H-tetracene-2-carboxamide
InChI=1S/C21H22N2O8/c1-23(2)14-9-6-8-12(16(26)11-7(15(8)25)4-3-5-10(11)24)18(28)21(9,31)19(29)13(17(14)27)20(22)30/h3-5,8-9,14-15,24-26,29,31H,6H2,1-2H3,(H2,22,30)/t8-,9-,14+,15+,21-/m0/s1